• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外集落形成作为原发性乳腺癌的预后指标

Colony formation in vitro as a prognostic indicator for primary breast cancer.

作者信息

Aapro M S, Eliason J F, Krauer F, Alberto P

出版信息

J Clin Oncol. 1987 Jun;5(6):890-6. doi: 10.1200/JCO.1987.5.6.890.

DOI:10.1200/JCO.1987.5.6.890
PMID:3035110
Abstract

Cells from some, but not all, tumor biopsy samples form colonies when cultured in semi-solid media. The possibility that colony formation by progenitor cells in these tumors may reflect a more "aggressive" phenotype bearing clinical implications was examined in a series of 61 patients with primary breast cancer. Tumor cells from 32 samples formed colonies in vitro. There was no correlation between colony formation and any of the standard clinical parameters such as tumor size, nodal status, metastatic spread, or hormone receptor levels. Eighteen patients had inflammatory, locally advanced and/or detectable metastatic breast cancer at the time of surgery. Sixteen of these patients have progressed and 15 have died, with no relationship between colony formation and survival. For the 43 remaining patients, 23 had a tissue sample that gave rise to colonies in vitro; 14 of these have relapsed, with a median relapse-free survival (RFS) of 37.6 months, and eight have died with a median survival time of 46.8 months. This is compared with four relapses (median RFS not reached, P = .0043, Peto-Pike), and four deaths (median not reached, P = .1175) in the group without growth of the tumor specimen. These results indicate that colony formation is an independent prognostic parameter for breast cancer, which may be useful for selecting patients who would benefit from more intensive therapy.

摘要

部分(而非全部)肿瘤活检样本中的细胞在半固体培养基中培养时会形成集落。在一系列61例原发性乳腺癌患者中,研究了这些肿瘤中祖细胞形成集落的可能性是否可能反映出具有临床意义的更“侵袭性”表型。32个样本的肿瘤细胞在体外形成了集落。集落形成与任何标准临床参数(如肿瘤大小、淋巴结状态、转移扩散或激素受体水平)之间均无相关性。18例患者在手术时患有炎性、局部晚期和/或可检测到转移的乳腺癌。其中16例患者病情进展,15例死亡,集落形成与生存之间无关联。对于其余43例患者,23例患者的组织样本在体外形成了集落;其中14例复发,无复发生存期(RFS)中位数为37.6个月,8例死亡,中位生存时间为46.8个月。相比之下,肿瘤标本未生长的组中有4例复发(RFS中位数未达到,P = .0043,Peto-Pike),4例死亡(中位数未达到,P = .1175)。这些结果表明,集落形成是乳腺癌的一个独立预后参数,可能有助于选择能从更强化治疗中获益的患者。

相似文献

1
Colony formation in vitro as a prognostic indicator for primary breast cancer.体外集落形成作为原发性乳腺癌的预后指标
J Clin Oncol. 1987 Jun;5(6):890-6. doi: 10.1200/JCO.1987.5.6.890.
2
In vitro clonogenic growth and metastatic potential of human operable breast cancer.人可手术乳腺癌的体外克隆生长及转移潜能
Cancer Res. 1989 Oct 1;49(19):5288-93.
3
Hormone dependency of human breast neoplasms cultured in vitro in the stem cell assay.
J Natl Cancer Inst. 1985 Apr;74(4):767-70.
4
Colony forming ability of human breast carcinomas: lack of prognostic significance.人乳腺癌的集落形成能力:缺乏预后意义。
Br J Cancer. 1989 Aug;60(2):216-9. doi: 10.1038/bjc.1989.254.
5
Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.保乳手术后原位导管癌与浸润性乳腺癌同侧乳腺肿瘤复发情况的比较。
World J Surg Oncol. 2016 Apr 27;14:126. doi: 10.1186/s12957-016-0885-6.
6
Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent years.近年来,在诊断为可手术乳腺癌的患者中,肿瘤大小、淋巴结状态、分级、HER2 和雌激素受体状态仍然具有很强的价值。
Int J Cancer. 2013 Jan 15;132(2):E58-65. doi: 10.1002/ijc.27795. Epub 2012 Sep 21.
7
Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.I期(T1N0M0)和II期(T1N1M0)乳腺癌的病理预后因素:对644例患者的研究,中位随访时间为18年。
J Clin Oncol. 1989 Sep;7(9):1239-51. doi: 10.1200/JCO.1989.7.9.1239.
8
Relationship of steroid hormone receptors to the cloning of fresh breast cancer tissues.类固醇激素受体与新鲜乳腺癌组织克隆的关系。
Recent Results Cancer Res. 1984;94:276-82. doi: 10.1007/978-3-642-82295-7_30.
9
Carcinoma of the breast in women 30 years of age or younger.
Am Surg. 1980 Oct;46(10):548-50.
10
Colony growth of cells from primary breast carcinoma in soft agar culture.原发性乳腺癌细胞在软琼脂培养中的集落生长。
Jpn J Surg. 1984 May;14(3):212-6. doi: 10.1007/BF02469570.

引用本文的文献

1
G-Protein-coupled Estrogen Receptor 1 (GPER1) Overexpression Affects Aggressiveness of Cervical Carcinoma Cells Depending on Histological Entity.G蛋白偶联雌激素受体1(GPER1)的过表达对子宫颈癌细胞侵袭性的影响取决于组织学类型。
Cancer Genomics Proteomics. 2025 May-Jun;22(3):397-414. doi: 10.21873/cgp.20509.
2
The Potent Novel CDK4/6 Inhibitor TQB3616 in Hormone Receptor Positive Breast Cancer: Preclinical Characterization with in vitro and Human Tumor Xenograft Models.新型强效CDK4/6抑制剂TQB3616在激素受体阳性乳腺癌中的研究:体外及人肿瘤异种移植模型的临床前特征分析
Breast Cancer (Dove Med Press). 2023 Dec 8;15:899-912. doi: 10.2147/BCTT.S434973. eCollection 2023.
3
Isolation and Characterization of Novel Canine Osteosarcoma Cell Lines from Chemotherapy-Naïve Patients.
从化疗初治患者中分离和鉴定新型犬骨肉瘤细胞系。
Cells. 2023 Mar 27;12(7):1026. doi: 10.3390/cells12071026.
4
Bardoxolone-Methyl (CDDO-Me) Suppresses Androgen Receptor and Its Splice-Variant AR-V7 and Enhances Efficacy of Enzalutamide in Prostate Cancer Cells.巴多昔芬甲酯(CDDO-Me)抑制雄激素受体及其剪接变体AR-V7,并增强恩杂鲁胺在前列腺癌细胞中的疗效。
Antioxidants (Basel). 2020 Jan 12;9(1):68. doi: 10.3390/antiox9010068.
5
Multimodal actions of the phytochemical sulforaphane suppress both AR and AR-V7 in 22Rv1 cells: Advocating a potent pharmaceutical combination against castration-resistant prostate cancer.植物化学物萝卜硫素的多模态作用抑制 22Rv1 细胞中的 AR 和 AR-V7:提倡针对去势抵抗性前列腺癌的强效药物组合。
Oncol Rep. 2017 Nov;38(5):2774-2786. doi: 10.3892/or.2017.5932. Epub 2017 Aug 30.
6
Redox signalling to nuclear regulatory proteins by reactive oxygen species contributes to oestrogen-induced growth of breast cancer cells.活性氧对核调节蛋白的氧化还原信号传导有助于雌激素诱导的乳腺癌细胞生长。
Br J Cancer. 2015 May 12;112(10):1687-702. doi: 10.1038/bjc.2014.586.
7
Human tumor cloning assays: applications in clinical oncology and new antineoplastic agent development.人类肿瘤克隆分析:在临床肿瘤学和新型抗肿瘤药物研发中的应用
Cancer Metastasis Rev. 1988 Dec;7(4):357-71. doi: 10.1007/BF00051376.
8
Colony forming ability of human breast carcinomas: lack of prognostic significance.人乳腺癌的集落形成能力:缺乏预后意义。
Br J Cancer. 1989 Aug;60(2):216-9. doi: 10.1038/bjc.1989.254.